Positive high-level results from the TROPION-Lung01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant improvement for the dual primary endpoint of...
Fresenius Kabi announced the immediate availability in the U.S. of its citrate-free adalimumab biosimilar IDACIO® (adalimumab-aacf) for use in the treatment of chronic autoimmune diseases for all...
CorEvitas, LLC, the gold-standard provider of real-world evidence solutions for the life sciences industry, announced that it has received the 2023 BOBI (Best of...
SimonMed Imaging, one of the largest outpatient imaging providers in the US, announced it has completed the implementation of its third generation breast artificial...
